Farallon Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-350,000
| Closed | -$15.5M | – | 308 |
|
|
2021
Q2 | $15.5M | Hold |
350,000
| – | – | 0.06% | 109 |
|
|
2021
Q1 | $15.5M | Buy |
350,000
+150,000
| +75% | +$6.66M | 0.08% | 114 |
|
|
2020
Q4 | $11M | Buy |
+200,000
| New | +$11M | 0.07% | 104 |
|
|
2020
Q1 | – | Sell |
-354,082
| Closed | -$8.06M | – | 110 |
|
|
2019
Q4 | $8.06M | Buy |
+354,082
| New | +$8.06M | 0.05% | 97 |
|